FIB-4, used as a marker for liver fibrosis which is often associated with hyperglycemia and hyperlipidemia and of the same potential mechanism as metabolic cardiac fibrosis was attractive in that age as detected in our low group model iteration, platelets, AST and ALT are its formulaic components, however we did not find an association between FIB-4 and measures of diastolic dysfunction. The gene discussed is GPT; the disease is Hepatic fibrosis.